Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer by Liu, Yun et al.
Open Access
Available online http://breast-cancer-research.com/content/9/4/R40
Page 1 of 7
(page number not for citation purposes)
Vol 9 No 4 Research article
Accuracy of computed tomography perfusion in assessing 
metastatic involvement of enlarged axillary lymph nodes in 
patients with breast cancer
Yun Liu1, Massimo Bellomi2, Giovanna Gatti3 and Xuejun Ping1
1Ningxia Medical College Hospital, Yinchuan, Ningxia, 75004, China
2Department of Radiology, European Institute of Oncology and School of Medicine, University of Milan, Italy
3Department of Senology, European Institute of Oncology, Milan, Italy
Corresponding author: Massimo Bellomi, massimo.bellomi@ieo.it
Received: 25 Jan 2007 Revisions requested: 5 Apr 2007 Revisions received: 13 Jun 2007 Accepted: 5 Jul 2007 Published: 5 Jul 2007
Breast Cancer Research 2007, 9:R40 (doi:10.1186/bcr1738)
This article is online at: http://breast-cancer-research.com/content/9/4/R40
© 2007 Liu et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction The purpose of this study was to evaluate the
diagnostic accuracy of computed tomography (CT) perfusion in
differentiating metastatic from inflammatory enlarged axillary
lymph nodes in patients with breast cancer.
Methods Twenty-five patients with 26 locally advanced breast
tumors and clinically palpable axillary lymph nodes underwent
dynamic multi-detector CT (LightSpeed 16; General Electric
Company) at one scan per second for 150 seconds at the same
table position after 40 ml intravenous contrast injection at 4.0
ml/second. Semi-automatic calculation of values of perfusion
parameters – blood flow (BF), blood volume (BV), mean transit
time (MTT), and permeability surface (PS) – was performed.
Results were compared with pathology and with Her-2/neu and
Ki-67 levels in a surgical specimen of the primary tumor.
Results Examined lymph nodes were inflammatory in 8 cases
and metastatic in 18. Mean values of perfusion parameters in
inflammatory and metastatic nodes, respectively, were BF of
76.18 (confidence interval [CI], 31.53) and 161.60 (CI, 40.94)
ml/100 mg per minute (p < 0.05), BV of 5.81 (CI, 2.50) and
9.15 (CI, 3.02) ml/100 mg (not significant [n.s.]), MTT of 6.80
(CI, 1.55) and 5.50 (CI, 1.84) seconds (p = 0.07), and PS of
25.82 (CI, 4.62) and 25.96 (CI, 7.47) ml/100 mg per minute
(n.s.). Size of nodes, stage of breast cancer, Ki-67 and Her-2/
neu levels in breast cancer, and expression of primary tumor
activity were not correlated to any perfusion parameter in
metastatic nodes.
Conclusion CT perfusion might be an effective tool for studying
enlarged axillary lymph nodes in patients with breast cancer. It
gives information on vascularization of lymph nodes, helping to
understand the changes occurring when neoplastic cells
implant in lymph nodes.
Introduction
Metastatic spread of tumor cells is responsible for the majority
of cancer deaths. Tumor cell dissemination is mediated by a
number of mechanisms, including local tissue invasion, lym-
phatic spread, hematogenous spread, or direct seeding of
body cavities or surfaces. Clinical and pathological observa-
tions have strongly suggested that, for many tumors, the most
common pathway of initial dissemination is via the lymphatics,
with patterns of spread via afferent vessels following routes of
natural drainage [1-3]. Cancer characterization, choice of
treatment, and prognosis are strictly linked to the lymphatic
local spread, lymph node metastases, and distance metas-
tases. At present, there is no accepted accurate imaging
modality or technique for the diagnosis of lymph node metas-
tases [4-6] and this is one of the major limits of imaging tech-
niques in tumor staging.
Functional imaging techniques, including dynamic contrast-
enhanced computed tomography (CT), are an emerging tool
proposed to evaluate blood supply and kinetics, to act as an in
BF = blood flow; BV = blood volume; CT = computed tomography; CTp = computed tomography perfusion; HU = Hounsfield units; i.v. = intravenous; 
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vivo marker of neo-angiogenesis, and to help diagnose tumors
and monitor tumor response [7-9]. Functional data provided
by CT perfusion (CTp) parameters and the related functional
maps may add some diagnostic value to the simple
morphologic CT images and increase the accuracy in diagnos-
ing metastatic lymph nodes.
The aims of this prospective study were to evaluate the diag-
nostic accuracy of CTp in the differential diagnosis of benign
or malignant enlarged axillary lymph nodes in patients with
breast cancer and to correlate CTp parameters with the index
of tumor aggressiveness, presuming that CTp mirrors angio-
genetic activity.
Materials and methods
Subjects
This study was approved by our Institute Ethics Committee,
and written informed consent was obtained from all patients.
The inclusion criteria were patients with cytology- or histology-
proven breast cancer, candidates to surgery with axillary dis-
section, and the presence of at least one palpable axillary
lymph node that was well defined and easily clinically identifi-
able. This node was defined as the 'target' node in our
research. Twenty-five consecutive patients who met the inclu-
sion criteria were prospectively enrolled (one patient had bilat-
eral breast cancer and bilaterally enlarged axillary lymph
nodes). The cutaneous projection of the target node was
marked on the skin with an indelible felt pen. The mean age
was 55.4 years (range, 36 to 79 years). All patients were
women.
Computed tomography perfusion technique
CTp was performed as an additional examination for patients
within 48 hours prior to surgical axillary nodal dissection. CTp
was performed using a 16-slice multi-detector CT scanner
(LightSpeed 16; General Electric Company, Fairfield, CT,
USA). Table position at the level of the marked target node
was recorded while defining the scan range by the external
laser alignment light. A preliminary non-contrast 2.5-mm-thick
CT of the axillar region (from the supraclavicular fossa to the
diaphragmatic muscle cacumen) was performed to guarantee
a panoramic view of the entire anatomical region and thus to
help the recognition of anatomical landmarks. The target node
was identified on the images, verifying the alignment of the
table position with that recorded when centering the patient.
A scanning range of 20 mm was selected for the dynamic CT
to include the maximum volume of the target node. Dynamic
study of this volume was performed (120 kV and 200 mA)
reconstructing four contiguous 5-mm slices and scanning at
the same table position at 1 second gantry rotation time, with
150 seconds total duration and no delay, after injection of 40
ml of non-ionic iodinated contrast medium (Iomeron 400 mg of
iodine/milliliter; Bracco Imaging SpA, Milan, Italy) at 4 ml/sec-
ond, followed by 40 ml of saline at 2 ml/second, via an 18- to
20-gauge cannula in the contralateral antecubital vein (in the
right arm of the patient with bilateral breast cancer). After con-
trast material administration, six dynamic CT acquisitions were
performed with breath-hold at the following intervals: 0–35,
40–45, 50–55, 60–65, 70–75, and 120–150 s. The timing
and intervals were chosen to obtain a high number of measure-
ments in the increasing part of the enhancement curves, which
has a high and fast variability, whereas a smaller number of
measurements is required in the washout phase, where these
changes are slower. During each of the six dynamic perfusion
series, the women received a local dose of 20 mGy and an
effective dose of 1 mSv. With Montecarlo simulation software
(CT-Expo, Medizinische Hochschule/Experimentelle Radiolo-
gie, Hannover, Germany) [10], the estimated dose to the
breast was set at 0.3 mSv per series and 1.8 mSv for the entire
study. A standard reconstruction algorithm with no edge
enhancement was used for dynamic scanning.
Image data analysis
Images and data obtained were transferred to an image-
processing workstation (Advantage Windows 4.2; General
Electric Company) and analyzed by a single expert reader (2
years of experience on CTp), who was blinded to pathology
results. Commercially available software (CT perfusion 3;
General Electric Company) was used for perfusion CTp anal-
ysis. In one of the four slices, a region of interest (ROI) small
enough to avoid partial volume effects (2 to 6 pixels) was
placed in the aorta (or subclavian artery or axillary artery when
the aorta was not included in the section) for calculation of the
arterial input, and a circular ROI (area range, 100 to 300 mm2)
was placed in the Teres major or subcapsularis muscle for
internal standard reference control. A third ROI was hand-
drawn along the visible margins of the node (Figure 1). The
software provided automated calculation of the following per-
fusion parameters in the ROI areas: blood flow (BF) in millilit-
ers per 100 mg per minute, blood volume (BV) in milliliters per
100 mg, mean transit time (MTT) of the contrast medium
through the ROI area in seconds, and permeability surface
(PS) area product, which measures contrast medium extrava-
sation into the extravascular space, in milliliters per 100 mg
per minute. Values of perfusion parameters were averaged
across three or four slices; when the target node was not vis-
ible in one slice, the set of slices was eliminated.
Pathological evaluation
The target node was identified by the surgeon before the skin
incision and marked by a suture on the specimen. Tumor tis-
sue and node specimens were fixed with 10% buffered forma-
lin and embedded in paraffin. The lymph nodes were bisected
along the major axis and were sliced at 3- to 4-mm intervals
before being fixed in 10% neutral buffered formalin for 6 to 8
hours under vacuum at 37°C. All the available tissue slices
were then dehydrated, cleared, and embedded in paraffin.
From the paraffin blocks, pairs of sections were cut at 50-μm
intervals until complete sectioning of the nodes was achieved.
One section of each pair was routinely stained with hematoxy-Available online http://breast-cancer-research.com/content/9/4/R40
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lin and eosin, whereas the mirror sections were kept
unstained. The metastatic foci up to 2 mm in greatest dimen-
sion were reported as micrometastases; those larger than 2
mm define the node as metastatic.
Her-2/neu and Ki-67 levels were performed in the surgical
specimen of the primary tumor; a polyclonal antibody for Ki-67
(Dako Denmark A/S, Glostrup, Denmark) was used at 1:350
dilution. Sections for Ki-67 were microwave-treated in 0.01 M
citrate buffer (pH 6.0) at 750 W for 10 minutes to enhance
antigen retrieval.
Statistical analysis
A descriptive analysis of BF, BV, MTT, and PS was performed;
mean values, standard deviations, and confidence intervals of
metastatic and inflammatory nodes were calculated. The dif-
ferences between BF, BV, MTT, and PS values of metastatic
and inflammatory lymph nodes were evaluated applying a non-
parametric Mann-Whitney U test for two independent groups.
The linear correlation coefficient (Pearson's r) was calculated
to estimate the correlation between CTp values and Ki-67 or
Her-2/neu levels in the primary breast tumor.
Results
Eleven out of 25 patients had right breast cancer, 13 had left
breast cancer, and 1 had synchronous bilateral breast cancer.
The locations of the 26 primary breast tumors were upper
outer quadrant (5), upper inner quadrant (7), lower inner quad-
rant (7), lower outer quadrant (4), and central (3). The primary
breast carcinoma was invasive ductal carcinoma in 20 cases,
invasive lobular carcinoma in 4 cases, and mixed invasive duc-
tal and lobular carcinoma in 2 cases.
The 26 lymph nodes examined by CTp were all identified in the
surgical specimen and at pathology. They were metastatic in
18 cases and negative for metastases in 8 cases, which were
all diagnosed as inflammatory hyperplasia. The mean maximum
diameter of examined nodes was 1.42 cm. The mean diame-
ters of metastatic and normal nodes were 1.60 and 1.24 cm,
respectively.
All acquisitions were successful and could be analyzed by the
software. Values of perfusion parameters (± standard devia-
tion) obtained from the ROI in the muscle were BF of 13.48 ±
5.35 ml/100 mg per minute, BV of 1.16 ± 0.65 ml/100 mg,
MTT of 9.85 ± 3.49 seconds, and PS of 4.44 ± 3.26 ml/100
mg per minute.
At CTp, the mean areas of ROI drawn along the examined
nodes were 12.9 cm2 for inflammatory nodes and 23.2 cm2 for
metastatic nodes. The difference between the areas of meta-
static and inflammatory nodes was not significant (p = 0.376).
BF, BV, MTT, and PS mean values of inflammatory (Figure 2)
and metastatic (Figure 3) axillary lymph nodes are detailed in
Table 1. The difference between the two groups is significant
for measurements of BF, but not significant for those of other
parameters. Of the 18 patients with metastatic nodes, 6 were
staged as N1, 7 as N2, and 5 as N3; no correlation was found
between any of the perfusion parameters evaluated in the tar-
get node and the N staging. In the same group of patients, the
primary tumor was pathologically staged as T1 in 7 patients, T2
in 4, T3 in 6, and T4 in 1; the mean values of BF, BV, MTT, and
PS in the four groups of patients showed no differences.
In patients with metastatic nodes, neither Ki-67 nor Her-2/neu
levels in the primary breast cancer were significantly corre-
lated to CTp parameter values (BF, BV, MTT, and PS).
Discussion
Axillary nodal status is the most significant prognostic factor
for predicting survival in patients with breast cancer even
though many other factors such as tumor size, histological
grade, S-phase fraction, DNA index, tumor ploidy, estrogen
receptor and progesterone receptor status, and Her-2/neu
and Ki-67 status have provided additional information to guide
adjuvant therapy [11]. The accuracy of different imaging tech-
niques in assessing axillary node status was extensively inves-
tigated. Ultrasound, implemented by power Doppler, showed
a patient-based sensitivity of 86% and specificity of 93% [12].
Magnetic resonance imaging (MRI) with ultrasmall superpara-
Figure 1
Image from one of the slices obtained by dynamic computed tomogra- phy centered on the palpable axillary node in patient AF with right  breast carcinoma Image from one of the slices obtained by dynamic computed tomogra-
phy centered on the palpable axillary node in patient AF with right 
breast carcinoma. A region of interest (ROI) was manually drawn along 
the margins of the target node (3). ROIs 1 and 2 were positioned in the 
axillary artery and vein. They were chosen with a very small area, as sug-
gested by the software designer, to avoid partial volume effects. ROI 4 
was drawn in the Teres major muscle for control.Breast Cancer Research    Vol 9 No 4    Liu et al.
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magnetic iron oxide (USPIO) demonstrated a node-by-node
sensitivity ranging from 100% to 73% and specificity ranging
from 98% to 80% in the assessment of axillary node metas-
tases and in pre-surgical staging of patients with breast
cancer [13-15]. Nevertheless, clinicians consider the accu-
racy of imaging in defining lymph node metastases insufficient
to drive the therapeutic decision and they prefer to base the
type of surgery on the surgical biopsy and histology examina-
tion of axillary nodes in patients with breast cancer. Diagnosis
of nodal status is generally obtained by sentinel node biopsy
[16,17], but the evidence of palpable nodes contraindicates
sentinel node biopsy and indicates total axillary dissection
[18]. However, because of inflammation, a significant percent-
age of enlarged nodes (30% in our series, which is similar to
figures reported in the literature [19,20]) are hyperplastic, and
a correct pre-surgical diagnosis could spare unnecessary sur-
gery that is associated with significant morbidity such as par-
esthesia, hematoma, seroma, restricted shoulder motion, and
lymphedema [19].
The diagnosis of metastatic lymph nodes, which has an impor-
tant clinical impact, is one of the main research fields in devel-
oping new imaging technologies or new contrast media. A
recent study, based on ultrasound imaging of the primary
tumor vascularization, showed that axillary involvement and
cell proliferation are more frequent in highly vascularized
tumors and that there seems to be a correlation between
tumor vascularization and axillary node involvement [21].
Dynamic CT and perfusion parameters mirror tissue vasculari-
zation and might reflect angiogenic activity [22-24] and thus,
theoretically, may be able to differentiate neoplastic from non-
neoplastic tissue. A recent paper by Goh and colleagues [25]
demonstrated that the inflammation of the intestinal wall is
characterized by higher perfusion parameters than normal tis-
sue, but by lower perfusion parameters than neoplastic tissue.
The increased perfusion and permeability of inflamed tissue
may be due to the effect of cytokines, which provokes vasodil-
atation and increases endothelial permeability, even if not at
such high levels as neoplastic tissue, where angiogenesis
plays an important role. The changes occurring in lymph nodes
are probably different from those of solid tissues. The results
obtained in our study show a significant difference of BF in
metastatic and inflammatory enlarged axillary nodes. No signif-
icant differences were found in the other perfusion parameters
(BV and PS), whereas the MTT values in metastatic nodes
were lower than in inflammatory nodes (p  = 0.07). We
employed a commercially available software that was based
on CT attenuation numbers obtained by a simple dynamic CT
scan with intravenous (i.v.) injection of conventional contrast
medium. The basic theory of CT perfusion software is based
on the measure of blood supply to the ROI and its leakage into
intercellular spaces. The changes induced by metastatic cells
implanted in a lymph node are mainly expressed by blood ves-
sel overgrowth and architectural disorganization [26]. Neo-
plastic and inflammatory infiltration have a similar behavior
Figure 2
Map of perfusion of patient in Figure 1 Map of perfusion of patient in Figure 1. The colored scale perfusion 
map designed using software shows how the perfusion of the target 
node is similar to that of the muscle. At post-surgical pathology, no 
metastases were found in the node.
Figure 3
Colored map of blood volume (BV) in a patient with right breast cancer  and omolateral palpable node Colored map of blood volume (BV) in a patient with right breast cancer 
and omolateral palpable node. Both the primary tumor (outlined by 
region of interest [ROI] 5) and the target node (outlined by ROI 6) are 
visible on this slice. High values of BV are depicted both in the primary 
tumor and in the target node. At post-surgical pathology, the lymph 
node was determined to be metastatic.Available online http://breast-cancer-research.com/content/9/4/R40
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when invading extravascular space, and the difference
between inflammatory and malignant changes is difficult to
appreciate on the basis of criteria such as size [27] or even
function of lymph node, as demonstrated by the similar pattern
often observed by USPIO-MRI images [13,15,28]. This could
be one of the reasons why we observed no differences in PS
and MTT of metastatic and inflammatory enlarged axillary
nodes: PS reflects the rate of leakage from the intravascular to
extravascular-extracellular space within the capillary bed and
MTT reflects the transit time through the vascular bed, being
predominantly affected by the presence of shunts. Whereas in
metastatic nodes BF is increased by newly developed vessels
from angiogenetic activity, the changes in vascular endothe-
lium and in the function of vessels induced by neo-angiogen-
esis and by cytokine-mediated inflammation are similar and
values of PS and MTT are not different. Also, BV increases in
metastatic nodes, but the difference does not reach statistical
significance. Our results are in keeping with the observations
by Yuen and colleagues [29], who described a higher CT con-
trast enhancement of metastatic axillary nodes than of non-
metastatic ones: the simple measurement of density values
after i.v. contrast medium administration were significantly dif-
ferent only after 1 minute, when metastatic nodes reached a
density of 78.1 ± 27.8 Hounsfield units (HU) compared to 6.3
± 32.7 HU of normal nodes. The early enhancement shown in
their series of metastatic nodes probably reflects the higher
blood supply due to angiogenesis, even if the simple protocol
used was unable to study the contrast and blood dynamics
and to draw significant conclusions. A recent paper by Bisdas
and colleagues [30] reports no significant difference in CTp
parameters between normal and metastatic nodes in patients
with oropharyngeal cancer. Our data show higher values of BF
in both inflammatory and metastatic nodes than those
reported by Bisdas and colleagues. The difference in size and
location of nodes might partially explain this difference. As
speculated by Lurie and colleagues [31], the enhancement of
lymph nodes starts in the subcapsular sinus and progresses to
the medullar sinus; both neoplastic and inflammatory infiltra-
tion mainly occur in subcapsular spaces and the enlargement
of this area may be one of the factors responsible for an
increased blood supply, mirrored by an increase of BF.
The lack of a relationship between tumor biological activity and
CTp values in metastatic lymph nodes is probably due to the
different features investigated. Although both mirror tumor
aggressiveness, tumor markers are associated with cellular
proliferation, whereas CTp is probably related to the angio-
genetic process.
The present study has some limitations. The series is limited
and unbalanced (69.2% of metastatic nodes and 30.8% of
inflammatory nodes), thus making it unreliable to evaluate the
sensitivity and specificity of the results. The technique requires
the identification of the node to be examined and the analysis
is restricted to a range of 20 mm, thus preventing the examina-
tion of the whole axillary lymphatic bed. No data on completely
normal nodes are available since it was impossible to identify
small normal nodes observed at CT scan at subsequent sur-
gery and pathological examination to confirm their normality.
The unknown cardiac output of patients might influence the
calculation of CTp values. The radiation dose of CTp might
cause some concern for the contralateral breast, included in
the scan field of view; the effective dose can be reduced by
lowering x-ray tube energy for the dynamic scan, as suggested
by Miles and colleagues [32]. Finally, the physiopathology and
dynamics of blood supply to normal, inflammatory, and meta-
static lymph nodes are not yet thoroughly understood and fur-
ther studies on this topic and its relationship with CTp are
needed.
Conclusion
Our study suggests that CTp may provide useful information
on lymph node status, adding functional to morphologic data.
The use of multi-detector CT allows diagnosticians to reach a
high spatial definition, and information on vascularization pro-
vided by CTp could be integrated with that of other diagnostic
Table 1
BF, BV, MTT and PS mean values in inflammatory and metastatic axillary nodes
Parameter Blood flow (milliliters per
100 mg per minute)
Blood volume
(milliliters per 100 mg)
Mean transit time (seconds) Permeability surface 
(milliliters per 100 mg per 
minute)
Node Inflammatory Metastatic Inflammatory Metastatic Inflammatory Metastatic Inflammatory Metastatic
Mean value 76.18 161.60 5.81 9.15 6.80 5.50 25.82 25.96
Standard deviation 45.51 88.63 3.61 6.54 2.24 3.98 6.67 16.17
Confidence interval 31.53 40.94 2.50 3.02 1.55 1.84 4.62 7.47
P value <0.05 0.1 0.07 0.84
Mean values, standard deviations (SD) and confidence intervals (CI) of blood flow (BF), blood volume (BV), mean transit time (MTT) and 
permeability surface (PS) values for metastatic and inflammatory nodes. The p values of the Mann-Whitney U test are reported in the table. The 
Mann-Whitney U test proved a statistically significant difference between blood flow values of metastatic and inflammatory nodes (p < 0.05). 
However, the tests did not prove that the differences between the other parameters are statistically significant.Breast Cancer Research    Vol 9 No 4    Liu et al.
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techniques to better understand the changes occurring in
lymph nodes following neoplastic cell implantation and
development.
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